Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AUTL | AZN | AMGN | GILD | VRTX |
| Company | Autolus Therapeutics Plc ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.5100 | 70.96 | 274.18 | 108.11 | 444.37 |
| High | 1.5892 | 70.98 | 275.59 | 108.77 | 445.16 |
| Low | 1.5100 | 70.22 | 272.10 | 107.39 | 438.68 |
| Last | 1.5500 | 70.57 | 273.11 | 108.59 | 439.76 |
| Change | +0.0200 | +0.65 | -1.90 | -0.52 | -7.42 |
| % Change | +1.31% | +0.93% | -0.69% | -0.48% | -1.66% |
| Volume | 512,949 | 1,943,435 | 488,573 | 2,169,474 | 376,132 |
| 20-Day Average Volume | 2,483,619 | 5,258,349 | 2,806,118 | 9,265,267 | 2,088,509 |
| Previous Close | 1.5300 | 69.92 | 275.01 | 109.11 | 447.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3483 | 69.64 | 276.42 | 102.90 | 461.47 |
| 20-Day Raw Stochastic | 89.94% | 70.14% | 39.13% | 94.24% | 25.48% |
| 20-Day Relative Strength | 53.60% | 52.23% | 44.74% | 55.14% | 41.61% |
| Weighted Alpha | -63.42 | -9.22 | -13.10 | +59.25 | -7.13 |
| Today's Opinion | 64% Sell | 40% Sell | 88% Sell | 64% Buy | 56% Sell |
| Previous Opinion | 64% Sell | 72% Sell | 72% Sell | 64% Buy | 56% Sell |
| Last Month's Opinion | 88% Sell | 72% Sell | 56% Sell | 40% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.64% since 05/14/25 | +6.81% since 05/14/25 | +4.24% since 05/14/25 | +10.12% since 05/14/25 | +4.61% since 05/14/25 |
| Low | 1.1850 on 05/15/25 | 67.07 on 05/15/25 | 264.15 on 05/15/25 | 97.86 on 05/15/25 | 421.76 on 05/15/25 |
| High | 1.5892 on 05/21/25 | 70.97 on 05/21/25 | 276.90 on 05/20/25 | 109.25 on 05/20/25 | 448.00 on 05/20/25 |
| 1-Month | |||||
| %Chg | +7.29% since 04/21/25 | +5.74% since 04/21/25 | -0.10% since 04/21/25 | +3.84% since 04/21/25 | -7.73% since 04/21/25 |
| Low | 1.1500 on 05/07/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 1.7200 on 04/23/25 | 72.69 on 05/06/25 | 292.00 on 04/30/25 | 109.25 on 05/20/25 | 510.77 on 04/30/25 |
| 3-Month | |||||
| %Chg | -20.77% since 02/21/25 | -4.69% since 02/21/25 | -9.77% since 02/21/25 | -1.46% since 02/21/25 | -9.01% since 02/21/25 |
| Low | 1.1050 on 04/11/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 2.1300 on 03/05/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -45.60% since 11/21/24 | +10.08% since 11/21/24 | -5.69% since 11/21/24 | +20.70% since 11/21/24 | -2.17% since 11/21/24 |
| Low | 1.1050 on 04/11/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 3.4500 on 12/02/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 407,196 | 216,839,184 | 147,874,528 | 135,725,088 | 114,834,480 |
| Shares Outstanding, K | 266,141 | 3,101,247 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 10,120,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -220,660,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 8,980,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -70,160,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 1.77 | 0.40 | 0.51 | 0.26 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 05/08/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/08/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.13 | 13.29 | 13.72 | 0.00 |